Activation of the TCL1 protein in B cell lymphomas

Citation
I. Nakayama et al., Activation of the TCL1 protein in B cell lymphomas, PATHOL INT, 50(3), 2000, pp. 191-199
Citations number
21
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
PATHOLOGY INTERNATIONAL
ISSN journal
13205463 → ACNP
Volume
50
Issue
3
Year of publication
2000
Pages
191 - 199
Database
ISI
SICI code
1320-5463(200003)50:3<191:AOTTPI>2.0.ZU;2-B
Abstract
The TCL1 gene, localized near the break point of chromosome 14q32.1 often i nvolved in T cell leukemias, is also expressed in normal precursor T and B cells, and B cell lymphoma cell lines. We investigated the expression of th e TCL1 protein in various types of B cell lymphomas according to the Revise d European-American Classification of Lymphoid neoplasms, Paraffin-embedded tissue sections of lymphoma specimens were subjected to TCL1 immunohistoch emistry, and positivity was scored on a three-tiered scale: - (< 25% cells) , + (25-50% cells), and ++ (> 50% cells). The TCL1 protein was expressed in low-grade B cell lymphomas including mucosa-associated lymphoid tissue typ e in ocular adnexa (18/20, 90%), It was also expressed in follicular, lymph oplasmacytic, and mantle cell lymphoma, but not in high-grade diffuse large B cell lymphoma (2/11, 18%). These data suggest that the expression of the TCL1 gene characterizes low-grade B cell lymphomas, and may be involved in certain processes of lymphomatogenesis.